Sun Pharma Adv reported an impressive 314.11% year-over-year increase in consolidated net sales for June 2026, reaching Rs 39.92 crore.

India's Sun Pharma announced a higher quarterly profit, driven by strong market demand for its products.

Sun Pharma has announced its intention to acquire Innovcare Lifesciences in a deal valued at $28.7 million.

Sun Pharma has obtained a bridge loan to finance its $12 billion acquisition of Organon.

Evercore ISI reports that talk of a potential deal between Sun Pharma and Organon & Co. (OGN) lacks confirmation and remains speculative.

The generic drugmakers, with many more expected to make announcements, are eyeing a share of the market for Semaglutide in India, which is estimated to be $1 billion over the next couple of years

Sun Pharma has successfully won a U.S. antitrust appeal concerning a settlement related to the drug Lipitor, marking a significant legal victory for the company, with multiple outlets confirming the development.

Shareholders of Organon & Co. have cleared the merger deal with Sun Pharma, paving the way for the integration of the two companies.

India's leading bank has committed $1 billion in funding to support Sun Pharma's acquisition deal in the United States.

India's Sun Pharma has announced its acquisition of the US-based pharmaceutical company Organon for approximately $12 billion. This deal represents one of the largest overseas pharma acquisitions for an Indian company.

Organon shares saw a jump in early trading after reports emerged of a potential bid from Sun Pharmaceutical.

Leading pharmaceutical company Sun Pharma has initiated a recall of 10 eye drop products in India due to a contamination scare, stating all necessary steps are being taken for patient safety.

Terapia, a SUN PHARMA company, in collaboration with the Romanian Society of Dermatology, launched an initiative where doctors cycled to show solidarity and support for individuals living with psoriasis and other autoimmune conditions.

India's Sun Pharma is set to enter the "big leagues" of the pharmaceutical industry following a significant $12 billion deal in the United States. This acquisition or partnership is expected to substantially expand its market presence and influence.

Organon's shares jumped 15% after Sun Pharma reportedly agreed to an $11.8 billion buyout deal. The acquisition news significantly boosted Organon's stock performance.

Organon's stock saw an increase following reports that Sun Pharma is close to a $12 billion buyout agreement for the company.